Trials / Conditions / Peritoneal Metastasis

Peritoneal Metastasis

13 registered clinical trials studyying Peritoneal Metastasis — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metast NCT07405736	Sun Yat-sen University	Phase 2
Recruiting	A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritone NCT07349043	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 1
Not Yet Recruiting	Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE) NCT07241715	National University Hospital, Singapore	Phase 2 / Phase 3
Not Yet Recruiting	The Value of 68Ga-FAPI PET/CT for Evaluating Peritoneal Treatment Response NCT06957782	Erasmus Medical Center	N/A
Not Yet Recruiting	Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic G NCT06914687	Fudan University	Phase 2
Active Not Recruiting	SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases NCT06940921	Zhang Tao	Phase 1 / Phase 2
Recruiting	A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diag NCT07107633	Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.	Phase 2
Recruiting	The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer wi NCT06597526	Ruijin Hospital	—
Unknown	Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC NCT05544253	West China Hospital	Phase 2 / Phase 3
Completed	ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture NCT06102278	Chen Xiaoping	—
Unknown	The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites NCT02779608	Fudan University	Phase 2
Unknown	Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer NCT02591667	Medical University of Vienna	Phase 2
Completed	Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Ova NCT01242436	Universitaire Ziekenhuizen KU Leuven	N/A